Llame gratis :
1 (855) MEDVIN-1
Psoriatic Arthritis
Multiple studies available for this indication - criteria differs.
An FDA approved medication for Psoriasis is being investigated for the treatment for Psoriatic Arthritis (PsA). One injection every 3 months for 12 months. Psoriatic arthritis is a chronic inflammatory condition that affects the joints, causing pain, swelling, and stiffness. This study aims to evaluate the potential of new therapies in managing PsA symptoms and improving patient outcomes.
Criterios de participación
Must have a diagnosis of PsA for at least 6 months.
BMI over 27 (Obesity or Overweight)
Must have 3 tender, 3 swollen joints
Exclusion: Not qualified with a HX of Type 1 or 2 Diabetes
Exclusion: Have a prior or planned surgical treatment for obesity
Ubicaciones participantes
Tujunga, Menifee, Riverside, Whittier, Apple Valley, Covina
